Iannitto, E., Bellei, M., Amorim, S., Ferreri, A. J. M., Marcheselli, L., Cesaretti, M., Haioun, C., Mancuso, S., Bouabdallah, K., Gressin, R., Tripodo, C., Traverse‐Glehen, A., Baseggio, L., Zupo, S., Stelitano, C., Castagnari, B., Patti, C., Alvarez, I., Liberati, A. M., Merli, M., Gini, G., Cabras, M. G., Dupuis, J., Tessoulin, B., Perrot, A., Re, F., Palombi, F., Gulino, A., Zucca, E., Federico, M., & Thieblemont, C. (2018). efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study. British journal of haematology, 183, 755–765. http://access.bl.uk/ark:/81055/vdc_100073684433.0x00005e